Page 4 - நிகழ்நிலை முதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VCM Analyzer Novel VCM showed correlation between clotting time and unfractionated heparin (UFH) superior to “gold standard” aPTT method in single-center study Providing clinicians with diagnostic tools that simplify the monitoring of critically ill patients is crucial to improving outcomes during the COVID-19 pandemic” John B. Mowell, Entegrion Chairman and Executive Director DURHAM, NC, U.S., January 5, 2021 /EINPresswire.com/ Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly released publication of a single-center study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) as a novel device to assess coagulation at the bedside. In the study, published in the Online First section of the ASAIO Journal, UFH dose was better correlated with the VCM than with Activated Partial Thromboplastin Time (aPTT), considered the “gold standard” for UFH monitoring

Jack mowellGranda ospedale policlinicoJohnb mowellEntegrion incEntegrion chairmanViscoelastic coagulation monitorOnline firstActivated partial thromboplastin timePrincipal investigator mauro panigadaExecutive chairmanNew pointCare viscoelastic coagulation monitoring systemMajor abdominalUnfractionated heparinபலா மோவேல்ழ்நிகழ்நிலை முதல்